semaglutide and cardiovascular disease The weight-loss drug Wegovy lowered heart attack risk in a large trial Semaglutide Effects on Cardiovascular Outcomes

Dave covers this week's news in GLP-1 and anti-obesity medicine news.#RETATRUTIDE #ENOBARSARM #zepbound Decoding GLP-1: A Guide for Friends and Family of Tho...

GLP-1, naturally produced in the gut, helps regulate appetite, manage blood sugar levels, and support overall digestion and weight management

Clinical trials (ten studies, 419 participants) using doses from 400 mg to 10 g over 21 days to 20 months show consistent reductions in fasting glucose, post-meal glucose, and HbA1c. In diabetic animal studies, gymnema increased proglucagon gene expression (a precursor for GLP-1) and insulin gene activity, suggesting it may help amplify endogenous GLP-1 production

Lot 6040411 COA issued 07/06/2026 Independent lab-verified data for potency, heavy metals & microbiology

PlexusDx explains the clinical evidence around semaglutide use after pancreatitis and how to work with your doctor on personalized weight loss options